Cannabis compounds CBG and THC tested for pain and hunger boost
NCT ID NCT04859296
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether vaporized cannabigerol (CBG) and THC can help with pain and appetite. Twenty occasional cannabis users will receive different doses of CBG and THC, alone or together, and report their pain tolerance, hunger, and any side effects. The goal is to see if these compounds are safe and effective for these symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cannabigerol (CBG) and Delta-9-tetrahydrocannabinol (THC) vaporized
What this could lead to
If it works, this could point toward a treatment for pain and appetite loss using cannabis compounds.
What could go wrong
This is a very small, early-phase study with only 20 participants. Results may not apply to everyone, and the compounds may cause intoxication or abuse potential.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, Los Angeles
Los Angeles, California, 90095, United States